TY - JOUR
T1 - TERAVOLT
T2 - Thoracic Cancers International COVID-19 Collaboration
AU - Whisenant, Jennifer G.
AU - Trama, Annalisa
AU - Torri, Valter
AU - De Toma, Alessandro
AU - Viscardi, Giuseppe
AU - Cortellini, Alessio
AU - Michielin, Olivier
AU - Barlesi, Fabrice
AU - Dingemans, Anne Marie C.
AU - Van Meerbeeck, Jan
AU - Pancaldi, Vera
AU - Soo, Ross A.
AU - Leighl, Natasha B.
AU - Peters, Solange
AU - Wakelee, Heather
AU - Garassino, Marina Chiara
AU - Horn, Leora
N1 - Publisher Copyright:
© 2020
PY - 2020/6/8
Y1 - 2020/6/8
N2 - Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.
AB - Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.
UR - http://www.scopus.com/inward/record.url?scp=85084989800&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2020.05.008
DO - 10.1016/j.ccell.2020.05.008
M3 - Comment/debate
C2 - 32425702
AN - SCOPUS:85084989800
SN - 1535-6108
VL - 37
SP - 742
EP - 745
JO - Cancer Cell
JF - Cancer Cell
IS - 6
ER -